Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01542307 · ClinicalTrials.gov registry record · Phase 2
Normobaric Oxygen (NBO) Therapy in Acute Migraine
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT01542307: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT01542307 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01542307, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
This is a pilot study investigating the therapeutic potential of breathing 100% oxygen in acute migraine headache.
Interventions
- BIOLOGICAL Oxygen
- BIOLOGICAL Room air
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01542307
The ClinicalTrials.gov registry entry for NCT01542307 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxygen is the first listed.
NCT01542307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01542307 about?
NCT01542307 is a clinical study titled "Normobaric Oxygen (NBO) Therapy in Acute Migraine". This is a pilot study investigating the therapeutic potential of breathing 100% oxygen in acute migraine headache.
What is the current status of trial NCT01542307?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2012-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01542307?
The interventions under investigation include: Oxygen (BIOLOGICAL), Room air (BIOLOGICAL).
Who is sponsoring clinical trial NCT01542307?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.